Literature DB >> 10626675

An agonist anti-human CD40 monoclonal antibody that induces dendritic cell formation and maturation and inhibits proliferation of a myeloma cell line.

Z H Zhou1, J F Wang, Y D Wang, Y H Qiu, J Z Pan, W Xie, L Y Jiang, B Klein, X G Zhang.   

Abstract

CD40, a 48-50 KD cell membrane molecule, member of the nerve growth factor receptor and tumor necrosis factor receptor superfamily, is an important costimulatory molecule during the immune response. Anti-CD40 monoclonal antibody (MAb) has been shown earlier to costimulate with IgM or phorbol esters resting B cells to proliferate, differentiate, secrete immunoglobulins, and switch isotype. Here we report on an agonistic mouse anti-human CD40 MAb 5C11. The specificity of this MAb was verified by flow cytometry, Western blotting, and competition with anti-CD40 MAb 89. We studied the effects of MAb 5C11 on a multimyeloma cell line, XG2, that expresses the CD40 antigen strongly and found that this MAb caused the homotypic aggregation of XG2, strongly suppressed XG2 proliferation, and led to its apoptosis after 24 hr of treatment. Interestingly, MAb 5C11 also triggered the generation, proliferation, and maturation of dendritic cells from peripheral blood monocytes, either by itself or in combination with GM-CSF and IL-4.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10626675     DOI: 10.1089/hyb.1999.18.471

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  7 in total

1.  PD-L1 mediated the differentiation of tumor-infiltrating CD19+ B lymphocytes and T cells in Invasive breast cancer.

Authors:  Honggeng Guan; Yang Lan; Yuqiu Wan; Qin Wang; Cheng Wang; Longjiang Xu; Yongjing Chen; Wenting Liu; Xueguang Zhang; Yecheng Li; Yongping Gu; Zemin Wang; Fang Xie
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

2.  Sensitization of SiHa cell to gemcitabine by CD40 activation and its overexpression in cervical carcinoma.

Authors:  Qin Huang; Qiu-Xia Qu; Fang Xie; Jian-Ming Hu; You-Guo Chen; Xue-Guang Zhang
Journal:  Med Oncol       Date:  2010-05-14       Impact factor: 3.064

Review 3.  Understanding cytokine and growth factor receptor activation mechanisms.

Authors:  Mariya Atanasova; Adrian Whitty
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-10-09       Impact factor: 8.250

4.  Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum.

Authors:  Guangbo Zhang; Jianquan Hou; Jinfang Shi; Gehua Yu; Binfeng Lu; Xueguang Zhang
Journal:  Immunology       Date:  2008-01-09       Impact factor: 7.397

5.  An immunological electrospun scaffold for tumor cell killing and healthy tissue regeneration.

Authors:  Xingzhi Liu; Hongbo Zhang; Ruoyu Cheng; Yanzheng Gu; Yin Yin; Zhiyong Sun; Guoqing Pan; Zhongbin Deng; Huilin Yang; Lianfu Deng; Wenguo Cui; Hélder A Santos; Qin Shi
Journal:  Mater Horiz       Date:  2018-08-16       Impact factor: 13.266

6.  The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1+ regulator B cells mediates immunosuppression in triple-negative breast cancer.

Authors:  Xuejiao Li; Huan Du; Shenghua Zhan; Wenting Liu; Zhangyu Wang; Jing Lan; Longxiang PuYang; Yuqiu Wan; Qiuxia Qu; Sining Wang; Yang Yang; Qin Wang; Fang Xie
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

7.  Ex vivo assays of dendritic cell activation and cytokine profiles as predictors of in vivo effects in an anti-human CD40 monoclonal antibody ChiLob 7/4 phase I trial.

Authors:  F Chowdhury; P W Johnson; M J Glennie; A P Williams
Journal:  Cancer Immunol Res       Date:  2013-11-21       Impact factor: 11.151

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.